GlassScriptPhysician profile
Kathryn T Weber
NPI 1265775274
$3,319.72
in general payments reported to CMS, 2019-2025
28 companies · $441 in 2025
The $441 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $33.99 · 2022: $944 · 2023: $1,535 · 2024: $366 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,568 · Travel and Lodging: $774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,567.64 |
| Travel and Lodging | $774.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thd America, INC. | $1,214.29 | 2022-2023 | |
| Medtronic, INC. | $354.32 | 2024-2025 | Ligasure, Signia, Interstim |
| Intuitive Surgical, INC. | $235.92 | 2022-2024 | |
| Davol INC. | $193.59 | 2022-2025 | Arista |
| Takeda Pharmaceuticals U.S.A., INC. | $168.93 | 2021-2025 | Entyvio, Trintellix |
| Novo Nordisk INC | $130.24 | 2022-2023 | Rybelsus, Ozempic |
| Vertex Pharmaceuticals Incorporated | $123.80 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $118.82 | 2022 | |
| Baxter Healthcare | $99.34 | 2022 | |
| Integra Lifesciences Corporation | $78.65 | 2022 | |
| Exact Sciences Corporation | $72.64 | 2023 | Cologuard Collection Kit |
| Bausch Health US, LLC | $68.31 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.82 | 2022-2023 | Plenvu |
| Braintree Laboratories, INC. | $41.09 | 2022 | |
| Glaxosmithkline, LLC. | $40.34 | 2022-2023 | Trelegy Ellipta |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $38.77 | 2023 | |
| Ibsa Pharma INC. | $36.36 | 2022 | |
| Lilly USA, LLC | $34.79 | 2022-2023 | Jardiance |
| Idorsia Pharmaceuticals US INC | $30.34 | 2022 | |
| Innovation Technologies INC | $30.05 | 2022 | |
| Convatec INC. | $26.36 | 2023 | |
| Eisai INC. | $24.08 | 2022 | |
| Monaghan Medical Corporation | $18.81 | 2023 | Aerochamber |
| Northgate Technologies, INC. | $18.81 | 2023 | Smoke Removel - Nebulae |
| Ardelyx, INC. | $18.60 | 2024 | Ibsrela |
| Tela Bio, INC. | $17.34 | 2022 | |
| Acera Surgical, INC. | $16.99 | 2021 | |
| Merck Sharp & Dohme LLC | $13.32 | 2023 | Belsomra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Weber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.